The mechanism of action of aminophylline upon cerebral vascular disorders.
D000628:Aminophylline / Q000494:pharmacology* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000503:physiopathology; D002245:Carbon Dioxide; D002340:Carotid Artery Diseases / Q000188:drug therapy / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D006985:Hyperventilation / Q000503:physiopathology; D007269:Injections, Intra-Arterial; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008579:Meningioma / Q000503:physiopathology; D008722:Methods; D008875:Middle Aged; D010313:Partial Pressure; D011868:Radioisotopes; D012039:Regional Blood Flow / Q000187:drug effects*; D014662:Vasoconstrictor Agents; D014978:Xenon
D011868:Radioisotopes; D014662:Vasoconstrictor Agents; D002245:Carbon Dioxide; D000628:Aminophylline; D014978:Xenon